Num | GO | Overlap | Size | P Value | Adj. P Value |
1 |
TISSUE DEVELOPMENT |
42 |
1518 |
1.587e-26 |
7.384e-23 |
2 |
ORGAN MORPHOGENESIS |
31 |
841 |
1.624e-22 |
3.779e-19 |
3 |
EPITHELIUM DEVELOPMENT |
32 |
945 |
3.582e-22 |
5.556e-19 |
4 |
PATTERN SPECIFICATION PROCESS |
24 |
418 |
9.9e-22 |
1.152e-18 |
5 |
EMBRYO DEVELOPMENT |
30 |
894 |
1.376e-20 |
1.281e-17 |
6 |
REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
38 |
1784 |
1.202e-19 |
9.322e-17 |
7 |
EMBRYONIC MORPHOGENESIS |
24 |
539 |
3.718e-19 |
2.471e-16 |
8 |
REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY |
17 |
207 |
4.201e-18 |
2.443e-15 |
9 |
REGIONALIZATION |
19 |
311 |
9.658e-18 |
4.993e-15 |
10 |
TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY |
16 |
190 |
2.969e-17 |
1.382e-14 |
11 |
ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY |
24 |
689 |
1.005e-16 |
4.251e-14 |
12 |
GLAND DEVELOPMENT |
19 |
395 |
8.031e-16 |
3.114e-13 |
13 |
HEART DEVELOPMENT |
20 |
466 |
1.108e-15 |
3.966e-13 |
14 |
CARDIOVASCULAR SYSTEM DEVELOPMENT |
24 |
788 |
2.025e-15 |
6.281e-13 |
15 |
CIRCULATORY SYSTEM DEVELOPMENT |
24 |
788 |
2.025e-15 |
6.281e-13 |
16 |
POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY |
12 |
100 |
4.803e-15 |
1.397e-12 |
17 |
SKELETAL SYSTEM DEVELOPMENT |
19 |
455 |
1.051e-14 |
2.876e-12 |
18 |
POSITIVE REGULATION OF GENE EXPRESSION |
32 |
1733 |
1.799e-14 |
4.65e-12 |
19 |
RESPONSE TO GROWTH FACTOR |
19 |
475 |
2.282e-14 |
5.588e-12 |
20 |
POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
25 |
1004 |
4.569e-14 |
1.063e-11 |
21 |
REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT |
31 |
1672 |
4.922e-14 |
1.091e-11 |
22 |
POSITIVE REGULATION OF BIOSYNTHETIC PROCESS |
32 |
1805 |
5.599e-14 |
1.184e-11 |
23 |
RESPONSE TO BMP |
11 |
94 |
9.407e-14 |
1.824e-11 |
24 |
CELLULAR RESPONSE TO BMP STIMULUS |
11 |
94 |
9.407e-14 |
1.824e-11 |
25 |
REGULATION OF CELL DIFFERENTIATION |
29 |
1492 |
1.343e-13 |
2.47e-11 |
26 |
DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION |
20 |
602 |
1.38e-13 |
2.47e-11 |
27 |
TISSUE MORPHOGENESIS |
19 |
533 |
1.791e-13 |
3.086e-11 |
28 |
CELL FATE COMMITMENT |
14 |
227 |
2.552e-13 |
4.242e-11 |
29 |
TUBE DEVELOPMENT |
19 |
552 |
3.333e-13 |
5.348e-11 |
30 |
NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
21 |
740 |
6.38e-13 |
9.895e-11 |
31 |
ANTERIOR POSTERIOR PATTERN SPECIFICATION |
13 |
194 |
6.771e-13 |
1.016e-10 |
32 |
ACTIVIN RECEPTOR SIGNALING PATHWAY |
7 |
22 |
1.859e-12 |
2.651e-10 |
33 |
NEGATIVE REGULATION OF CELL DIFFERENTIATION |
19 |
609 |
1.88e-12 |
2.651e-10 |
34 |
TUBE MORPHOGENESIS |
15 |
323 |
2.037e-12 |
2.787e-10 |
35 |
NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS |
21 |
801 |
2.89e-12 |
3.842e-10 |
36 |
MORPHOGENESIS OF AN EPITHELIUM |
16 |
400 |
3.325e-12 |
4.298e-10 |
37 |
EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING |
18 |
554 |
4.029e-12 |
5.067e-10 |
38 |
GROWTH |
16 |
410 |
4.826e-12 |
5.909e-10 |
39 |
POSITIVE REGULATION OF DEVELOPMENTAL PROCESS |
24 |
1142 |
6.274e-12 |
7.485e-10 |
40 |
NEGATIVE REGULATION OF GENE EXPRESSION |
27 |
1493 |
6.753e-12 |
7.855e-10 |
41 |
REGULATION OF CELL PROLIFERATION |
27 |
1496 |
7.075e-12 |
8.029e-10 |
42 |
EPITHELIAL CELL DIFFERENTIATION |
17 |
495 |
7.261e-12 |
8.044e-10 |
43 |
POSITIVE REGULATION OF CELL COMMUNICATION |
27 |
1532 |
1.227e-11 |
1.328e-09 |
44 |
SPECIFICATION OF SYMMETRY |
10 |
117 |
3.26e-11 |
3.447e-09 |
45 |
SEX DIFFERENTIATION |
13 |
266 |
3.674e-11 |
3.799e-09 |
46 |
EMBRYONIC ORGAN DEVELOPMENT |
15 |
406 |
5.232e-11 |
5.293e-09 |
47 |
REPRODUCTIVE SYSTEM DEVELOPMENT |
15 |
408 |
5.606e-11 |
5.55e-09 |
48 |
ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS |
21 |
957 |
8.086e-11 |
7.838e-09 |
49 |
REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION |
8 |
60 |
8.932e-11 |
8.481e-09 |
50 |
UROGENITAL SYSTEM DEVELOPMENT |
13 |
299 |
1.569e-10 |
1.46e-08 |
51 |
POSITIVE REGULATION OF CELL DIFFERENTIATION |
19 |
823 |
3.299e-10 |
3.01e-08 |
52 |
NEGATIVE REGULATION OF NITROGEN COMPOUND METABOLIC PROCESS |
25 |
1517 |
3.738e-10 |
3.345e-08 |
53 |
NEGATIVE REGULATION OF CELL PROLIFERATION |
17 |
643 |
4.243e-10 |
3.725e-08 |
54 |
REPRODUCTION |
23 |
1297 |
5.637e-10 |
4.858e-08 |
55 |
CELL DEVELOPMENT |
24 |
1426 |
6.144e-10 |
5.198e-08 |
56 |
HEART MORPHOGENESIS |
11 |
212 |
7.042e-10 |
5.851e-08 |
57 |
POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION |
7 |
48 |
7.392e-10 |
6.034e-08 |
58 |
RESPONSE TO ENDOGENOUS STIMULUS |
24 |
1450 |
8.599e-10 |
6.898e-08 |
59 |
MESODERM DEVELOPMENT |
9 |
118 |
9.26e-10 |
7.303e-08 |
60 |
EMBRYONIC ORGAN MORPHOGENESIS |
12 |
279 |
9.569e-10 |
7.42e-08 |
61 |
MORPHOGENESIS OF A BRANCHING STRUCTURE |
10 |
167 |
1.103e-09 |
8.412e-08 |
62 |
CELLULAR RESPONSE TO ENDOGENOUS STIMULUS |
20 |
1008 |
1.447e-09 |
1.086e-07 |
63 |
PALATE DEVELOPMENT |
8 |
85 |
1.552e-09 |
1.146e-07 |
64 |
POSITIVE REGULATION OF RESPONSE TO STIMULUS |
27 |
1929 |
2.202e-09 |
1.601e-07 |
65 |
POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS |
23 |
1395 |
2.309e-09 |
1.653e-07 |
66 |
BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE |
9 |
131 |
2.35e-09 |
1.657e-07 |
67 |
TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER |
17 |
724 |
2.56e-09 |
1.778e-07 |
68 |
MALE SEX DIFFERENTIATION |
9 |
148 |
6.901e-09 |
4.722e-07 |
69 |
REGULATION OF EPITHELIAL CELL PROLIFERATION |
11 |
285 |
1.554e-08 |
1.048e-06 |
70 |
ARTERY DEVELOPMENT |
7 |
75 |
1.83e-08 |
1.216e-06 |
71 |
MAMMARY GLAND DEVELOPMENT |
8 |
117 |
1.988e-08 |
1.303e-06 |
72 |
REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS |
10 |
229 |
2.299e-08 |
1.486e-06 |
73 |
ENDOCRINE SYSTEM DEVELOPMENT |
8 |
123 |
2.946e-08 |
1.878e-06 |
74 |
KIDNEY EPITHELIUM DEVELOPMENT |
8 |
125 |
3.343e-08 |
2.102e-06 |
75 |
NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS |
18 |
983 |
3.852e-08 |
2.39e-06 |
76 |
POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS |
19 |
1135 |
6.218e-08 |
3.807e-06 |
77 |
MESONEPHROS DEVELOPMENT |
7 |
90 |
6.57e-08 |
3.97e-06 |
78 |
NEUROGENESIS |
21 |
1402 |
7.21e-08 |
4.262e-06 |
79 |
CONNECTIVE TISSUE DEVELOPMENT |
9 |
194 |
7.236e-08 |
4.262e-06 |
80 |
DEVELOPMENTAL GROWTH |
11 |
333 |
7.619e-08 |
4.431e-06 |
81 |
POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS |
18 |
1036 |
8.519e-08 |
4.834e-06 |
82 |
POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS |
18 |
1036 |
8.519e-08 |
4.834e-06 |
83 |
SMAD PROTEIN SIGNAL TRANSDUCTION |
6 |
56 |
8.688e-08 |
4.87e-06 |
84 |
TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY |
7 |
95 |
9.565e-08 |
5.298e-06 |
85 |
CELLULAR RESPONSE TO ORGANIC SUBSTANCE |
24 |
1848 |
9.747e-08 |
5.335e-06 |
86 |
EMBRYONIC PATTERN SPECIFICATION |
6 |
58 |
1.076e-07 |
5.823e-06 |
87 |
GLAND MORPHOGENESIS |
7 |
97 |
1.105e-07 |
5.91e-06 |
88 |
CARTILAGE DEVELOPMENT |
8 |
147 |
1.181e-07 |
6.245e-06 |
89 |
EMBRYONIC HEART TUBE MORPHOGENESIS |
6 |
62 |
1.614e-07 |
8.44e-06 |
90 |
GASTRULATION |
8 |
155 |
1.778e-07 |
9.19e-06 |
91 |
DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS |
9 |
216 |
1.81e-07 |
9.253e-06 |
92 |
POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS |
21 |
1492 |
2.062e-07 |
1.043e-05 |
93 |
LUNG EPITHELIUM DEVELOPMENT |
5 |
34 |
2.151e-07 |
1.076e-05 |
94 |
VASCULATURE DEVELOPMENT |
12 |
469 |
2.965e-07 |
1.468e-05 |
95 |
CELL PROLIFERATION |
14 |
672 |
3.376e-07 |
1.654e-05 |
96 |
APPENDAGE DEVELOPMENT |
8 |
169 |
3.449e-07 |
1.655e-05 |
97 |
LIMB DEVELOPMENT |
8 |
169 |
3.449e-07 |
1.655e-05 |
98 |
FEMALE SEX DIFFERENTIATION |
7 |
116 |
3.777e-07 |
1.785e-05 |
99 |
REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS |
17 |
1021 |
3.797e-07 |
1.785e-05 |
100 |
IMMUNE SYSTEM DEVELOPMENT |
13 |
582 |
4.264e-07 |
1.984e-05 |
101 |
EMBRYONIC HEART TUBE DEVELOPMENT |
6 |
73 |
4.319e-07 |
1.99e-05 |
102 |
NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION |
5 |
40 |
4.994e-07 |
2.278e-05 |
103 |
EMBRYONIC SKELETAL SYSTEM DEVELOPMENT |
7 |
122 |
5.325e-07 |
2.405e-05 |
104 |
OSSIFICATION |
9 |
251 |
6.41e-07 |
2.868e-05 |
105 |
NEGATIVE REGULATION OF CELL COMMUNICATION |
18 |
1192 |
6.772e-07 |
3.001e-05 |
106 |
REGULATION OF CELL DEVELOPMENT |
15 |
836 |
8.12e-07 |
3.564e-05 |
107 |
MESENCHYME DEVELOPMENT |
8 |
190 |
8.394e-07 |
3.617e-05 |
108 |
STEM CELL DIFFERENTIATION |
8 |
190 |
8.394e-07 |
3.617e-05 |
109 |
KIDNEY MORPHOGENESIS |
6 |
82 |
8.637e-07 |
3.653e-05 |
110 |
NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION |
6 |
82 |
8.637e-07 |
3.653e-05 |
111 |
REGULATION OF GROWTH |
13 |
633 |
1.096e-06 |
4.581e-05 |
112 |
RESPIRATORY SYSTEM DEVELOPMENT |
8 |
197 |
1.103e-06 |
4.581e-05 |
113 |
NEURON DIFFERENTIATION |
15 |
874 |
1.414e-06 |
5.823e-05 |
114 |
CARDIAC CHAMBER DEVELOPMENT |
7 |
144 |
1.629e-06 |
6.592e-05 |
115 |
RESPONSE TO TRANSFORMING GROWTH FACTOR BETA |
7 |
144 |
1.629e-06 |
6.592e-05 |
116 |
REGULATION OF MAPK CASCADE |
13 |
660 |
1.742e-06 |
6.988e-05 |
117 |
NEPHRON EPITHELIUM DEVELOPMENT |
6 |
93 |
1.817e-06 |
7.224e-05 |
118 |
POSITIVE REGULATION OF REPRODUCTIVE PROCESS |
5 |
52 |
1.901e-06 |
7.433e-05 |
119 |
POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION |
4 |
23 |
1.886e-06 |
7.433e-05 |
120 |
REGULATION OF PROTEIN MODIFICATION PROCESS |
21 |
1710 |
1.929e-06 |
7.479e-05 |
121 |
DIGESTIVE SYSTEM DEVELOPMENT |
7 |
148 |
1.957e-06 |
7.525e-05 |
122 |
MAMMARY GLAND EPITHELIUM DEVELOPMENT |
5 |
53 |
2.093e-06 |
7.981e-05 |
123 |
POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY |
4 |
24 |
2.256e-06 |
8.534e-05 |
124 |
RESPONSE TO ESTROGEN |
8 |
218 |
2.353e-06 |
8.828e-05 |
125 |
REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY |
4 |
25 |
2.678e-06 |
9.967e-05 |
126 |
OUTFLOW TRACT MORPHOGENESIS |
5 |
56 |
2.76e-06 |
0.0001019 |
127 |
REGULATION OF T CELL DIFFERENTIATION IN THYMUS |
4 |
26 |
3.155e-06 |
0.0001147 |
128 |
REGULATION OF THYMOCYTE AGGREGATION |
4 |
26 |
3.155e-06 |
0.0001147 |
129 |
POSITIVE REGULATION OF CELL PROLIFERATION |
14 |
814 |
3.255e-06 |
0.0001164 |
130 |
REGULATION OF CELL DEATH |
19 |
1472 |
3.267e-06 |
0.0001164 |
131 |
REGULATION OF PHOSPHORUS METABOLIC PROCESS |
20 |
1618 |
3.278e-06 |
0.0001164 |
132 |
CARDIAC CHAMBER MORPHOGENESIS |
6 |
104 |
3.494e-06 |
0.0001232 |
133 |
POSITIVE REGULATION OF HEMOPOIESIS |
7 |
163 |
3.718e-06 |
0.0001301 |
134 |
IN UTERO EMBRYONIC DEVELOPMENT |
9 |
311 |
3.753e-06 |
0.0001303 |
135 |
REGULATION OF HEMOPOIESIS |
9 |
314 |
4.058e-06 |
0.0001399 |
136 |
EMBRYONIC DIGIT MORPHOGENESIS |
5 |
61 |
4.232e-06 |
0.0001448 |
137 |
NEGATIVE REGULATION OF RESPONSE TO STIMULUS |
18 |
1360 |
4.433e-06 |
0.0001506 |
138 |
EMBRYONIC HINDLIMB MORPHOGENESIS |
4 |
29 |
4.967e-06 |
0.0001675 |
139 |
NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS |
5 |
66 |
6.261e-06 |
0.0002066 |
140 |
NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY |
5 |
66 |
6.261e-06 |
0.0002066 |
141 |
NEPHRON DEVELOPMENT |
6 |
115 |
6.26e-06 |
0.0002066 |
142 |
REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION |
5 |
67 |
6.745e-06 |
0.000221 |
143 |
ORGAN GROWTH |
5 |
68 |
7.258e-06 |
0.0002362 |
144 |
NEGATIVE REGULATION OF T CELL DIFFERENTIATION |
4 |
32 |
7.453e-06 |
0.0002408 |
145 |
NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS |
6 |
121 |
8.391e-06 |
0.0002693 |
146 |
CELL CELL SIGNALING |
13 |
767 |
8.933e-06 |
0.0002847 |
147 |
REGULATION OF CELLULAR COMPONENT MOVEMENT |
13 |
771 |
9.444e-06 |
0.0002989 |
148 |
MYELOID CELL DIFFERENTIATION |
7 |
189 |
9.831e-06 |
0.0003091 |
149 |
ERYTHROCYTE HOMEOSTASIS |
5 |
73 |
1.03e-05 |
0.0003216 |
150 |
OSTEOBLAST DIFFERENTIATION |
6 |
126 |
1.059e-05 |
0.0003284 |
151 |
REGULATION OF NEURON DIFFERENTIATION |
11 |
554 |
1.097e-05 |
0.000338 |
152 |
FOREBRAIN DEVELOPMENT |
9 |
357 |
1.14e-05 |
0.000349 |
153 |
NEGATIVE REGULATION OF HEMOPOIESIS |
6 |
128 |
1.159e-05 |
0.0003523 |
154 |
REGULATION OF REPRODUCTIVE PROCESS |
6 |
129 |
1.211e-05 |
0.0003636 |
155 |
REGULATION OF ERYTHROCYTE DIFFERENTIATION |
4 |
36 |
1.206e-05 |
0.0003636 |
156 |
POSITIVE REGULATION OF CATENIN IMPORT INTO NUCLEUS |
3 |
12 |
1.272e-05 |
0.0003774 |
157 |
RESPONSE TO ALCOHOL |
9 |
362 |
1.273e-05 |
0.0003774 |
158 |
HINDLIMB MORPHOGENESIS |
4 |
37 |
1.349e-05 |
0.0003971 |
159 |
REGULATION OF SEQUENCE SPECIFIC DNA BINDING TRANSCRIPTION FACTOR ACTIVITY |
9 |
365 |
1.36e-05 |
0.0003979 |
160 |
REGULATION OF LYMPHOCYTE DIFFERENTIATION |
6 |
132 |
1.381e-05 |
0.0004017 |
161 |
RENAL TUBULE DEVELOPMENT |
5 |
78 |
1.425e-05 |
0.0004119 |
162 |
SKELETAL SYSTEM MORPHOGENESIS |
7 |
201 |
1.466e-05 |
0.0004212 |
163 |
NEURON PROJECTION GUIDANCE |
7 |
205 |
1.666e-05 |
0.0004755 |
164 |
METANEPHROS DEVELOPMENT |
5 |
81 |
1.714e-05 |
0.0004863 |
165 |
MAMMARY GLAND MORPHOGENESIS |
4 |
40 |
1.849e-05 |
0.0005215 |
166 |
NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION |
4 |
41 |
2.043e-05 |
0.0005667 |
167 |
POSITIVE REGULATION OF KIDNEY DEVELOPMENT |
4 |
41 |
2.043e-05 |
0.0005667 |
168 |
POSITIVE REGULATION OF OSSIFICATION |
5 |
84 |
2.046e-05 |
0.0005667 |
169 |
HEAD DEVELOPMENT |
12 |
709 |
2.084e-05 |
0.0005739 |
170 |
CARDIAC SEPTUM DEVELOPMENT |
5 |
85 |
2.167e-05 |
0.0005932 |
171 |
SENSORY ORGAN DEVELOPMENT |
10 |
493 |
2.376e-05 |
0.0006465 |
172 |
RESPONSE TO ESTRADIOL |
6 |
146 |
2.448e-05 |
0.0006622 |
173 |
CELL FATE DETERMINATION |
4 |
43 |
2.475e-05 |
0.0006657 |
174 |
MYELOID CELL HOMEOSTASIS |
5 |
88 |
2.565e-05 |
0.0006859 |
175 |
NEGATIVE REGULATION OF CELL DEVELOPMENT |
8 |
303 |
2.598e-05 |
0.0006895 |
176 |
GABAERGIC NEURON DIFFERENTIATION |
3 |
15 |
2.608e-05 |
0.0006895 |
177 |
LOCOMOTION |
15 |
1114 |
2.623e-05 |
0.0006896 |
178 |
ENDOCRINE PROCESS |
4 |
44 |
2.714e-05 |
0.0007095 |
179 |
AXIS SPECIFICATION |
5 |
90 |
2.86e-05 |
0.0007433 |
180 |
LUNG MORPHOGENESIS |
4 |
45 |
2.97e-05 |
0.0007678 |
181 |
DORSAL VENTRAL PATTERN FORMATION |
5 |
91 |
3.017e-05 |
0.0007735 |
182 |
SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION |
9 |
404 |
3.026e-05 |
0.0007735 |
183 |
POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION |
6 |
154 |
3.306e-05 |
0.0008407 |
184 |
CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION |
10 |
513 |
3.331e-05 |
0.0008424 |
185 |
CENTRAL NERVOUS SYSTEM DEVELOPMENT |
13 |
872 |
3.448e-05 |
0.0008672 |
186 |
REGULATION OF NERVOUS SYSTEM DEVELOPMENT |
12 |
750 |
3.615e-05 |
0.0009042 |
187 |
REGULATION OF LEUKOCYTE DIFFERENTIATION |
7 |
232 |
3.682e-05 |
0.0009162 |
188 |
ANTERIOR POSTERIOR AXIS SPECIFICATION |
4 |
48 |
3.844e-05 |
0.0009515 |
189 |
REGULATION OF CANONICAL WNT SIGNALING PATHWAY |
7 |
236 |
4.104e-05 |
0.001005 |
190 |
NEGATIVE REGULATION OF GROWTH |
7 |
236 |
4.104e-05 |
0.001005 |
191 |
RESPONSE TO LIPID |
13 |
888 |
4.16e-05 |
0.001013 |
192 |
EYE DEVELOPMENT |
8 |
326 |
4.366e-05 |
0.001058 |
193 |
EXTRINSIC APOPTOTIC SIGNALING PATHWAY |
5 |
99 |
4.527e-05 |
0.00108 |
194 |
REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY |
5 |
99 |
4.527e-05 |
0.00108 |
195 |
REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS |
5 |
99 |
4.527e-05 |
0.00108 |
196 |
OSTEOBLAST DEVELOPMENT |
3 |
18 |
4.638e-05 |
0.001095 |
197 |
SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION |
3 |
18 |
4.638e-05 |
0.001095 |
198 |
REGULATION OF ORGAN MORPHOGENESIS |
7 |
242 |
4.812e-05 |
0.001131 |
199 |
ARTERY MORPHOGENESIS |
4 |
51 |
4.893e-05 |
0.001144 |
200 |
CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION |
6 |
166 |
5.032e-05 |
0.001171 |
201 |
NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY |
5 |
102 |
5.223e-05 |
0.001209 |
202 |
POSITIVE REGULATION OF MOLECULAR FUNCTION |
19 |
1791 |
5.252e-05 |
0.00121 |
203 |
NEGATIVE REGULATION OF T CELL PROLIFERATION |
4 |
52 |
5.285e-05 |
0.001211 |
204 |
MESONEPHRIC TUBULE MORPHOGENESIS |
4 |
53 |
5.699e-05 |
0.0013 |
205 |
POSITIVE REGULATION OF PROTEIN IMPORT |
5 |
104 |
5.732e-05 |
0.001301 |
206 |
ODONTOGENESIS |
5 |
105 |
6e-05 |
0.001355 |
207 |
CARDIAC VENTRICLE DEVELOPMENT |
5 |
106 |
6.277e-05 |
0.001411 |
208 |
EPIDERMIS DEVELOPMENT |
7 |
253 |
6.37e-05 |
0.001425 |
209 |
EMBRYONIC HEMOPOIESIS |
3 |
20 |
6.442e-05 |
0.001434 |
210 |
REGULATION OF T CELL DIFFERENTIATION |
5 |
107 |
6.565e-05 |
0.001455 |
211 |
REGULATION OF KIDNEY DEVELOPMENT |
4 |
55 |
6.598e-05 |
0.001455 |
212 |
HOMEOSTASIS OF NUMBER OF CELLS |
6 |
175 |
6.748e-05 |
0.001481 |
213 |
REGULATION OF OSSIFICATION |
6 |
178 |
7.414e-05 |
0.001619 |
214 |
FORMATION OF PRIMARY GERM LAYER |
5 |
110 |
7.489e-05 |
0.001622 |
215 |
MALE GENITALIA DEVELOPMENT |
3 |
21 |
7.495e-05 |
0.001622 |
216 |
PROTEIN PHOSPHORYLATION |
13 |
944 |
7.763e-05 |
0.001672 |
217 |
REGULATION OF OSTEOBLAST DIFFERENTIATION |
5 |
112 |
8.158e-05 |
0.001749 |
218 |
REGULATION OF STEM CELL DIFFERENTIATION |
5 |
113 |
8.51e-05 |
0.001816 |
219 |
POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT |
3 |
22 |
8.653e-05 |
0.001839 |
220 |
REGULATION OF EMBRYONIC DEVELOPMENT |
5 |
114 |
8.873e-05 |
0.001877 |
221 |
STEM CELL PROLIFERATION |
4 |
60 |
9.294e-05 |
0.001948 |
222 |
POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION |
4 |
60 |
9.294e-05 |
0.001948 |
223 |
EPITHELIAL CELL DEVELOPMENT |
6 |
186 |
9.448e-05 |
0.001971 |
224 |
NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION |
3 |
23 |
9.923e-05 |
0.002061 |
225 |
POSITIVE REGULATION OF CELL DEVELOPMENT |
9 |
472 |
0.0001002 |
0.002072 |
226 |
CELL MOTILITY |
12 |
835 |
0.0001011 |
0.002073 |
227 |
LOCALIZATION OF CELL |
12 |
835 |
0.0001011 |
0.002073 |
228 |
CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION |
8 |
368 |
0.0001018 |
0.002078 |
229 |
REGULATION OF SMOOTHENED SIGNALING PATHWAY |
4 |
62 |
0.0001057 |
0.002148 |
230 |
MUSCLE TISSUE DEVELOPMENT |
7 |
275 |
0.0001073 |
0.00217 |
231 |
DEVELOPMENTAL MATURATION |
6 |
193 |
0.0001157 |
0.002331 |
232 |
POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT |
5 |
121 |
0.0001176 |
0.002358 |
233 |
MOVEMENT OF CELL OR SUBCELLULAR COMPONENT |
15 |
1275 |
0.0001216 |
0.002429 |
234 |
EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS |
3 |
25 |
0.0001281 |
0.002516 |
235 |
FOREBRAIN REGIONALIZATION |
3 |
25 |
0.0001281 |
0.002516 |
236 |
THYROID GLAND DEVELOPMENT |
3 |
25 |
0.0001281 |
0.002516 |
237 |
PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING |
3 |
25 |
0.0001281 |
0.002516 |
238 |
INOSITOL LIPID MEDIATED SIGNALING |
5 |
124 |
0.000132 |
0.00258 |
239 |
SOMATIC STEM CELL POPULATION MAINTENANCE |
4 |
66 |
0.0001349 |
0.002605 |
240 |
FOREBRAIN GENERATION OF NEURONS |
4 |
66 |
0.0001349 |
0.002605 |
241 |
MESODERM MORPHOGENESIS |
4 |
66 |
0.0001349 |
0.002605 |
242 |
NEURON FATE COMMITMENT |
4 |
67 |
0.0001431 |
0.002751 |
243 |
REGULATION OF MESONEPHROS DEVELOPMENT |
3 |
26 |
0.0001444 |
0.002766 |
244 |
NEGATIVE REGULATION OF CELL DEATH |
12 |
872 |
0.0001519 |
0.002897 |
245 |
REGULATION OF CELL GROWTH |
8 |
391 |
0.0001545 |
0.002934 |
246 |
POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS |
5 |
129 |
0.0001589 |
0.003005 |
247 |
NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION |
4 |
69 |
0.0001604 |
0.003022 |
248 |
REGULATION OF CATENIN IMPORT INTO NUCLEUS |
3 |
27 |
0.000162 |
0.00304 |
249 |
MAINTENANCE OF CELL NUMBER |
5 |
132 |
0.0001769 |
0.003306 |
250 |
SKIN EPIDERMIS DEVELOPMENT |
4 |
71 |
0.0001792 |
0.003309 |
251 |
ENDODERM DEVELOPMENT |
4 |
71 |
0.0001792 |
0.003309 |
252 |
CELL FATE SPECIFICATION |
4 |
71 |
0.0001792 |
0.003309 |
253 |
DOPAMINERGIC NEURON DIFFERENTIATION |
3 |
28 |
0.000181 |
0.003315 |
254 |
RESPONSE TO GONADOTROPIN |
3 |
28 |
0.000181 |
0.003315 |
255 |
NEURON PROJECTION MORPHOGENESIS |
8 |
402 |
0.0001866 |
0.003405 |
256 |
RESPONSE TO HORMONE |
12 |
893 |
0.0001895 |
0.003444 |
257 |
PANCREAS DEVELOPMENT |
4 |
73 |
0.0001995 |
0.003613 |
258 |
CELLULAR COMPONENT MORPHOGENESIS |
12 |
900 |
0.0002036 |
0.003672 |
259 |
REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION |
17 |
1656 |
0.0002106 |
0.003783 |
260 |
ODONTOGENESIS OF DENTIN CONTAINING TOOTH |
4 |
75 |
0.0002215 |
0.003964 |
261 |
REGULATION OF WNT SIGNALING PATHWAY |
7 |
310 |
0.0002242 |
0.003997 |
262 |
CARDIAC MUSCLE TISSUE DEVELOPMENT |
5 |
140 |
0.0002327 |
0.004132 |
263 |
DIENCEPHALON DEVELOPMENT |
4 |
77 |
0.0002452 |
0.004321 |
264 |
REGULATION OF BMP SIGNALING PATHWAY |
4 |
77 |
0.0002452 |
0.004321 |
265 |
HORMONE TRANSPORT |
4 |
78 |
0.0002576 |
0.004507 |
266 |
SOMITE DEVELOPMENT |
4 |
78 |
0.0002576 |
0.004507 |
267 |
ENDOCARDIAL CUSHION DEVELOPMENT |
3 |
32 |
0.0002709 |
0.004703 |
268 |
EMBRYONIC FORELIMB MORPHOGENESIS |
3 |
32 |
0.0002709 |
0.004703 |
269 |
POSITIVE REGULATION OF TRANSPORT |
12 |
936 |
0.0002917 |
0.005046 |
270 |
EMBRYONIC AXIS SPECIFICATION |
3 |
33 |
0.0002971 |
0.005114 |
271 |
POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION |
4 |
81 |
0.0002978 |
0.005114 |
272 |
MUSCLE STRUCTURE DEVELOPMENT |
8 |
432 |
0.0003034 |
0.00519 |
273 |
HAIR CYCLE |
4 |
83 |
0.000327 |
0.005553 |
274 |
MOLTING CYCLE |
4 |
83 |
0.000327 |
0.005553 |
275 |
RESPONSE TO WOUNDING |
9 |
563 |
0.0003717 |
0.006289 |
276 |
NEGATIVE REGULATION OF CELL ACTIVATION |
5 |
158 |
0.0004065 |
0.006853 |
277 |
CORONARY VASCULATURE DEVELOPMENT |
3 |
37 |
0.0004184 |
0.007028 |
278 |
EPITHELIAL CELL PROLIFERATION |
4 |
89 |
0.0004268 |
0.007143 |
279 |
POSITIVE REGULATION OF BIOMINERAL TISSUE DEVELOPMENT |
3 |
38 |
0.0004529 |
0.007527 |
280 |
MESENCHYME MORPHOGENESIS |
3 |
38 |
0.0004529 |
0.007527 |
281 |
ERBB2 SIGNALING PATHWAY |
3 |
39 |
0.0004893 |
0.008045 |
282 |
ANATOMICAL STRUCTURE MATURATION |
3 |
39 |
0.0004893 |
0.008045 |
283 |
TRABECULA MORPHOGENESIS |
3 |
39 |
0.0004893 |
0.008045 |
284 |
EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS |
4 |
93 |
0.0005043 |
0.008262 |
285 |
POSITIVE REGULATION OF MAPK CASCADE |
8 |
470 |
0.0005309 |
0.008608 |
286 |
FORELIMB MORPHOGENESIS |
3 |
40 |
0.0005275 |
0.008608 |
287 |
WOUND HEALING |
8 |
470 |
0.0005309 |
0.008608 |
288 |
CANONICAL WNT SIGNALING PATHWAY |
4 |
95 |
0.0005466 |
0.008831 |
289 |
POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT |
6 |
258 |
0.0005502 |
0.00884 |
290 |
POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION |
7 |
360 |
0.0005509 |
0.00884 |
291 |
NEGATIVE REGULATION OF CELL GROWTH |
5 |
170 |
0.0005675 |
0.008969 |
292 |
MYELOID LEUKOCYTE DIFFERENTIATION |
4 |
96 |
0.0005686 |
0.008969 |
293 |
AORTA DEVELOPMENT |
3 |
41 |
0.0005675 |
0.008969 |
294 |
CARDIOCYTE DIFFERENTIATION |
4 |
96 |
0.0005686 |
0.008969 |
295 |
PROSTATE GLAND DEVELOPMENT |
3 |
41 |
0.0005675 |
0.008969 |
296 |
BLOOD VESSEL MORPHOGENESIS |
7 |
364 |
0.0005882 |
0.009246 |
297 |
REGULATION OF HORMONE LEVELS |
8 |
478 |
0.0005931 |
0.009292 |
298 |
NEGATIVE REGULATION OF LOCOMOTION |
6 |
263 |
0.0006085 |
0.009484 |
299 |
GENITALIA DEVELOPMENT |
3 |
42 |
0.0006094 |
0.009484 |
300 |
POSITIVE REGULATION OF KINASE ACTIVITY |
8 |
482 |
0.0006263 |
0.009715 |
301 |
LIPID PHOSPHORYLATION |
4 |
99 |
0.0006386 |
0.009872 |